A new National Core Community Palliative Care Medicines List highlights the medicines community pharmacies should keep in stock.

Community pharmacies are often the first place people turn when something feels ‘off’. But as pharmacists know, many requests for over-the-counter medicines are more complex than they may initially seem.

A systematic review and meta-analysis found little evidence that cannabinoids improve outcomes for common conditions such as anxiety, post-traumatic stress disorder (PTSD) and other psychiatric disorders.

Opioid analgesic stewardship is now a national medicines safety priority, targeting preventable harm across acute settings and transitions to community care.

Adrenaline (epinephrine) nasal spray (neffy) was recently approved by the TGA and is now available for use in Australia.

Often complex, undiagnosed pelvic pain can leave patients in awful limbo. Pharmacists can help them understand what drives pain.

A recent systematic review has reignited debate about what happens when patients stop taking GLP-1 RAs and related incretin therapies.

The Therapeutic Goods Administration (TGA) has today (Monday 1 December) made updates to product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two...

Pharmacists are helping detect CKD sooner through point-of-care testing and risk assessment that connect at-risk patients with their GP. Chronic kidney disease (CKD) is a...

Questions about spacers are abundant in community pharmacy. AP answers some of the trickiest ones pharmacists face.